Insights from AUA 2024 Annual Meeting
Video Player is loading.
10 seconds
Playback speed
AUA 2024 Insights: "MoonRISe-1 Study - Erdafitinib-Releasing Intravesical Delivery System (TAR-210) vs. Intravesical Chemo in Intermediate-Risk NMIBC With FGFR Alterations"
By
Insights from AUA 2024 Annual Meeting
FEATURING
Roger Li
By
Insights from AUA 2024 Annual Meeting
FEATURING
Roger Li
Comments 0
Login to view comments.
Click here to Login
